A wholly-owned subsidiary of a large conglomerate based in Western Europe is engaged in advancing the role of nutritional therapy to change the course of health for consumers, patients and our partners in healthcare. The firm invests in life science assets at various stages of development through collaboration, in-licensing, or M&A. The company’s allocations are varied in both size and structure, and the company is open to partnerships globally.
The firm has a strong foundation of enteral and oral nutrition products in Aging Medical Care, Critical Care & Surgery, and Pediatric Medical Care (including inborn errors of metabolism) and endeavors to develop nutritional solutions to address chronic medical conditions in the area of gut health, metabolic Health, healthy aging, and allergy. For partnering, the company currently focuses on product opportunities and technologies (i.e. microbiome) that address the same, including our acute care interests, and that also elevate the role of nutrition or leverage natural approaches to prevent and treat conditions that impact consumers and patients alike.
The firm is seeking competent teams with science-based nutritional solutions to deliver improved personalized health care for people with medical conditions. Collaborators can benefit from working with the the firm’s vast R&D network, including a dedicated R&D Center located in Bridgewater, New Jersey.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 